Phage therapy against Pseudomonas aeruginosa : the next medical revolution
Gutiérrez León, Álvaro
Villaverde Corrales, Antonio, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Universitat Autònoma de Barcelona. Facultat de Biociències

Date:	2020
Abstract:	The rapid emergence of infections caused by multidrug-resistant Pseudomonas aeruginosa is becoming one of the most important concerns in the medical sector. Due to the failure of current antibiotic regimes in addressing this problem, the use of bacteriophages as potential pharmaceuticals has gained special attention in the past decade. This review offers a brief introduction to the complications associated to antibiotic-resistant P. aeruginosa and the advantages that phage therapy might offer in the matter. Then, it collects and discusses the most recent literature of this therapeutic approach in the context of P. aeruginosa, making a distinction among its three main categories: monophage, polyphage and phage-antibiotic complementation therapy. Finally, it examines the way in which the current legislation hinders research and investment on bacteriophages, and explains the reason why a new regulatory framework is needed for phage therapy.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Studies:	Biotecnologia [2500253]
Study plan:	Grau en Biotecnologia [815]
Document:	Treball final de grau ; Text
Subject:	Phage therapy ; Pseudomonas aeruginosa ; Antibiotic resistance ; Regulatory affairs

1 p, 6.7 MB

The record appears in these collections:
Research literature > Bachelor's degree final project > Biosciences Faculty